- Home
- BANR vs OCUL Comparison
BANR vs OCUL Comparison
Compare BANR & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANR | OCUL |
|---|---|---|
| Founded | 1890 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | 2015 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BANR | OCUL |
|---|---|---|
| Price | $61.87 | $8.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $71.20 | $23.56 |
| AVG Volume (30 Days) | 280.1K | ★ 4.1M |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | ★ 15.57 | N/A |
| EPS | ★ 5.64 | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | $0.73 | $7.93 |
| Revenue Next Year | $5.69 | $94.00 |
| P/E Ratio | $10.76 | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $54.01 | $6.23 |
| 52 Week High | $69.83 | $16.44 |
Technical Indicators
Market Signals| Indicator | BANR | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 59.64 | 47.01 |
| Support Level | $61.73 | $8.36 |
| Resistance Level | $65.31 | $12.38 |
| Average True Range (ATR) | 1.25 | 0.43 |
| MACD | 0.42 | -0.01 |
| Stochastic Oscillator | 99.33 | 64.46 |
Price Performance
Historical ComparisonAbout BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.